Liver Disease Treatments: The Global Market

Additional Information

INTRODUCTION

STUDY OBJECTIVES

BCC Research’s goal in conducting this study is to provide an overview of the current and future characteristics of the global market for liver disease drugs, including the market for end users. The key objective is to present a comprehensive analysis of the current liver disease drug market and its future direction by utilizing new methods for preventing globally widespread disease.

This report explores present and future strategies within the liver disease drug market, including market sizes, market leaders, market overview, and various other market factors, as well as the market for end users. The current state of the market, its setbacks, its innovations, and its future needs are also discussed.

A detailed analysis of the liver disease drug market and the industry structure has been conducted. This includes the different categories of liver disease drugs and the various types of liver disease broken down by market share belonging to leading manufacturers and/or suppliers. Revenues for each drug category and disease type are broken down by region. Sales figures are estimated for the 5-year period from 2011 through 2016.

The strategies and the prospects of the current market are also discussed. Companies that manufacture and sell new and innovative liver disease-related drugs are also profiled.

REASONS FOR DOING THIS STUDY

This study was conducted to provide detailed information regarding different liver disease drugs in response to an increasing need for new and innovative drug treatments. This industry is experiencing growth, as new product lines have been launched (e.g., Protease inhibitors for the treatment of hepatitis). The study looks at most of the different drug types and different liver diseases. It cites the research and development for almost all new drugs and applications. The changes in market behavior demonstrate the need to focus on this segment. Additionally, the study discusses the treatment options provided by these drugs to end users. Acquisitions, mergers, and alliances by companies and global organizations are also discussed.

INTENDED AUDIENCE

This study examines the areas of growth in the liver disease drug market from the point of view of both manufacturers and users. This study will be of interest largely to the pharmaceutical and biopharmaceutical industries, clinics, hospitals, and research institutes.

SCOPE OF THE STUDY

The scope of this study encompasses liver disease drug markets by various types. BCC Research analyzes each market by category with its applications in different regions of the world. It also analyzes the market leaders, regulatory environment, technology, market projections, and market share. Application issues include the latest trends and developments in each liver disease drug category.
METHODOLOGY

Both primary and secondary research methodologies were used in preparing this study. BCC conducted a comprehensive literature search, which included technical newsletters and journals, as well as many other sources. Data were collected through interviews and correspondence with various trade experts. Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.